loader
banner

Testimonials

Drug Discovery Partnerships

We focus on preclinical drug discovery where we aim to accelerate discovery and reduce experimental costs. We develop and use molecular dynamics simulations and machine learning.

  • An in-house GPU cluster so that your data will not leave our facilities.
  • 100% carbon-neutral electricity sources
  • Strong know-how on computer simulations and machine learning. See our publications in top-tier journals.
  • Proven collaborations with pharmaceutical companies.
  • We work with established CROs to deliver experimentially validated molecules.
  • 9.4/10 rating in Science Exchange.

Binding affinity prediction with machine learning

Predict protein-ligand binding affinity with proven accuracy.

Our propietary predictors (KDEEP, DeltaDelta, BindScope) have been published in peer-reviewed journals and validated in data from top pharmaceutical companies. Furthermore, KDEEP won two blind subchallenges of the D3R Grand Challenge 4 and it is now used daily in a large pharma company to perform their predictions.

Newsletter

Subscribe for Newsletter